Maryam Balibegloo

2 ta ish

Universal Scientific Education and Research Network

1. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons

   Seyed Aria Nejadghaderi, Maryam Balibegloo, Nima Rezaei

   MaqolaOAOchiq kirish20244 iqtibos

   ABIABI:AkademIndex/2026.other.138287

2. Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

   Simin Seyedpour, Behzad Khodaei, Amir Hossein Loghman +7

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.211001